Loading...
$280.0K
Awarded Sep 14, 2026
Competition
FULL AND OPEN COMPETITION
Offers
1
Set-Aside
None
Solicitation Type
SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
Performance Timeline
Start
Sep 30, 2026
Recompete planning should begin soon.
Contract: 75F40126F19005
UEI
MMT4LGM4H9Z5
Parent Company
DENVER HEALTH AND HOSPITAL AUTHORITY
Capabilities & Certifications
Headquarters Location
Congressional District: 01
Current Obligation
$279,973
Base + Exercised Options
$279,973
Total Ceiling Value
$330,746
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
Description
EO 14398 - POST-MARKETING RX DRUG ABUSE SURVEILLANCE DATA - DENVER HEALTH
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA
Place of Performance
Congressional District: 01
Awarding Agency
Top-tier Agency
Food and Drug Administration
Sub-tier Agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier Agency
Food and Drug Administration
Sub-tier Agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Contract Vehicle
75F40121D00033
IDCDepartment of Health and Human Services
Award Type: MULTIPLE AWARD